ChemoMetec A/S/€CHEMM
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX
About ChemoMetec A/S
ChemoMetec A/S is engaged in the development, manufacturing, and marketing of analytical instruments used for counting and analyzing cells in a variety of applications across biotechnology, pharmaceuticals, and academic research sectors. The company’s main product lines include automated cell counters and analyzers, such as the NucleoCounter series. Founded in 1997, ChemoMetec is headquartered in Allerod, Denmark. The company is noted for its focus on innovation in cell counting technology, providing precise and user-friendly solutions that facilitate laboratory workflows and enhance data accuracy. Its strategic position in the analytical instruments industry is strengthened by its commitment to quality and reliability in measurement instrumentation.
Ticker
€CHEMM
Sector
Primary listing
XGAT
Employees
170
Headquarters
Allerod, Denmark
Website
ChemoMetec A/S Metrics
BasicAdvanced
€1.6B
64.15
€1.43
1.53
€0.94
1.02%
Price and volume
Market cap
€1.6B
Beta
1.53
52-week high
€106.30
52-week low
€49.10
Average daily volume
11K
Dividend rate
€0.94
Financial strength
Current ratio
3.695
Quick ratio
2.91
Long term debt to equity
0.448
Total debt to equity
0.951
Dividend payout ratio (TTM)
37.34%
Interest coverage (TTM)
378.43%
Profitability
EBITDA (TTM)
33.157
Gross margin (TTM)
93.93%
Net profit margin (TTM)
37.61%
Operating margin (TTM)
47.73%
Effective tax rate (TTM)
22.34%
Revenue per employee (TTM)
€390,900
Management effectiveness
Return on assets (TTM)
19.65%
Return on equity (TTM)
30.10%
Valuation
Price to earnings (TTM)
64.154
Price to revenue (TTM)
24.128
Price to book
17.74
Price to tangible book (TTM)
22.96
Price to free cash flow (TTM)
83.783
Free cash flow yield (TTM)
1.19%
Free cash flow per share (TTM)
1.098
Dividend yield (TTM)
1.02%
Forward dividend yield
1.02%
Growth
Revenue change (TTM)
21.50%
Earnings per share change (TTM)
36.78%
3-year revenue growth (CAGR)
4.98%
10-year revenue growth (CAGR)
23.26%
3-year earnings per share growth (CAGR)
5.35%
10-year earnings per share growth (CAGR)
35.66%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for ChemoMetec A/S stock?
ChemoMetec A/S (CHEMM) has a market cap of €1.6B as of December 16, 2025.
What is the P/E ratio for ChemoMetec A/S stock?
The price to earnings (P/E) ratio for ChemoMetec A/S (CHEMM) stock is 64.15 as of December 16, 2025.
Does ChemoMetec A/S stock pay dividends?
Yes, the ChemoMetec A/S (CHEMM) stock pays dividends to shareholders. As of December 16, 2025, the dividend rate is €0.93703 and the yield is 1.02%. ChemoMetec A/S has a payout ratio of 37.34% on a trailing twelve-month basis.
When is the next ChemoMetec A/S dividend payment date?
The next ChemoMetec A/S (CHEMM) dividend payment date is unconfirmed.
What is the beta indicator for ChemoMetec A/S?
ChemoMetec A/S (CHEMM) has a beta rating of 1.53. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.